Catalyst Wire Dossier Catalyst Wire Dossier

Shingrix (recombinant zoster vaccine)

recombinant zoster vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Shingrix (recombinant zoster vaccine), covering 2025-04-01 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV [Phase 4]

See pricing